Katherine Hsiao, MD
Urogynecology and Reconstructive Pelvic Surgery · San Francisco, CANPI 1437237674
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,000 of the $10,920 with a category attached, or 73.3%. Intuitive Surgical accounts for 73.6% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2021 at $8,042 and has fallen 96.5% since, to $284 in 2025.
Across 60 payments — averaging $182.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- Hologic Sales And Service, LLC$2K
- AbbVie$311
- Acessa Health Inc.$266
- Johnson & Johnson$131
- Coopersurgical, Inc.$124
- plus $384 from 9 others
What the payments were for
- Speaking & faculty fees$8,00073%
- Travel & lodging$5355%
- Food & beverage$2,38522%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 3 | $8,033 |
| Hologic Sales And Service, LLC | 25 | $1,671 |
| AbbVie | 9 | $311 |
| Acessa Health Inc. | 1 | $266 |
| Johnson & Johnson | 1 | $131 |
| Coopersurgical, Inc. | 5 | $124 |
| Evofem Biosciences, Inc. | 4 | $79 |
| Myovant Sciences Inc. | 3 | $63 |
| Medtronic | 1 | $43 |
| Myriad Genetic Laboratories, Inc. | 1 | $43 |
| Stryker | 1 | $42 |
| Exact Sciences | 2 | $41 |
| Astellas Pharma US Inc | 2 | $37 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Boston Scientific | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$8,000
- ACESSA PROVU SYSTEM$1,355
- CoolSeal Generator$280
- Harmonic$131
- DERMABOND$131
- STRATAFIX$131
- MYOSURE TISSUE REMOVAL DEVICE$128
- Orilissa$116
How this compares
$10,920 in reported general payments places this provider in the 75th percentile of 130 urogynecology and reconstructive pelvic surgery providers in California.
See all urogynecology and reconstructive pelvic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ImvexxyEstradiol | 11 | $4,246 |
| Estradiol | 54 | $3,099 |
| DottiEstradiol | 18 | $2,790 |
| Estradiol (Twice Weekly)Estradiol | 21 | $2,558 |
| ProgesteroneProgesterone, Micronized | 35 | $1,104 |
| Raloxifene Hcl | 16 | $429 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in San Francisco
- Andrew BrillSan Francisco$345K
- Traci ItoSan Francisco$68K
- Bilal KaakiRiverside$301K
- Savitha KrishnanMountain View$243K
- Peter CastilloLos Gatos$95K
- Bruce Kahnla Jolla$79K
- Jennifer GruenenfelderOrange$76K
- Tanaz FerzandiLos Angeles$60K
- Sadikah BehbehaniCosta Mesa$53K
- Christopher TarnayLos Angeles$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.